{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:55:30Z","timestamp":1776873330121,"version":"3.51.2"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,21]]},"DOI":"10.7759\/cureus.56660","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:46:40Z","timestamp":1711068400000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Acute Kidney Injury, Proteinuria, and Thrombotic Microangiopathy Associated With Sunitinib Therapy in Metastatic Pancreatic Neuroendocrine Tumor"],"prefix":"10.7759","author":[{"given":"Lawanya","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Matassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/816897","article-title":"Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers","volume":"2011","author":"Escalante CP","year":"2011","unstructured":"Escalante CP, Zalpour A. Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers. Cardiol Res Pract. 2011, 2011:816897. 10.4061\/2011\/816897","journal-title":"Cardiol Res Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000241551","article-title":"Nephrotic syndrome and acute renal failure apparently induced by sunitinib","volume":"2","author":"Chen YS","year":"2009","unstructured":"Chen YS, Chen CL, Wang JS. Nephrotic syndrome and acute renal failure apparently induced by sunitinib. Case Rep Oncol. 2009, 2:172-6. 10.1159\/000241551","journal-title":"Case Rep Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis","volume":"56","author":"Ito T","year":"2021","unstructured":"Ito T, Masui T, Komoto I, et al.. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021, 56:1033-44. 10.1007\/s00535-021-01827-7","journal-title":"J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s4052","article-title":"Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma","volume":"2","author":"Schwandt A","year":"2009","unstructured":"Schwandt A, Wood LS, Rini B, Dreicer R. Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma. Onco Targets Ther. 2009, 2:51-61. 10.2147\/ott.s4052","journal-title":"Onco Targets Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Boll\u00e9e G","year":"2009","unstructured":"Boll\u00e9e G, Patey N, Cazajous G, et al.. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant. 2009, 24:682-5. 10.1093\/ndt\/gfn657","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm311","article-title":"A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","volume":"100","author":"Patel TV","year":"2008","unstructured":"Patel TV, Morgan JA, Demetri GD, George S, Maki RG, Quigley M, Humphreys BD. A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst. 2008, 100:282-4. 10.1093\/jnci\/djm311","journal-title":"J Natl Cancer Inst"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina V","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, et al.. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008, 358:1129-36. 10.1056\/NEJMoa0707330","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.172575","article-title":"Sunitinib-induced thrombotic microangiopathy","volume":"12","author":"Noronha V","year":"2016","unstructured":"Noronha V, Punatar S, Joshi A, Desphande RV, Prabhash K. Sunitinib-induced thrombotic microangiopathy. J Cancer Res Ther. 2016, 12:6-11. 10.4103\/0973-1482.172575","journal-title":"J Cancer Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/232565-a-case-of-acute-kidney-injury-proteinuria-and-thrombotic-microangiopathy-associated-with-sunitinib-therapy-in-metastatic-pancreatic-neuroendocrine-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:46:43Z","timestamp":1711068403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/232565-a-case-of-acute-kidney-injury-proteinuria-and-thrombotic-microangiopathy-associated-with-sunitinib-therapy-in-metastatic-pancreatic-neuroendocrine-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.56660","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}